Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment

In this study, incorporation of the cytotoxic agent paclitaxel and the P-glycoprotein inhibitor elacridar in hyaluronic acid (HA)-modified nanoemulsions was studied for intraductal delivery and breast cancer localized treatment. To improve cytotoxicity, we investigated the incorporation of perillyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Salata, Giovanna Cassone, Lopes, Luciana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503599/
https://www.ncbi.nlm.nih.gov/pubmed/36145331
http://dx.doi.org/10.3390/ph15091110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503599/
https://www.ncbi.nlm.nih.gov/pubmed/36145331
http://dx.doi.org/10.3390/ph15091110

Ejemplares similares